This inventor holds 2 USPTO granted patents. Top assignee: The Brigham and Women's Hospital, Inc.. Active years: 2020-2023.
Company Filing History:
Years Active: 2020-2023
Title: Piero Ricchiuto: Innovator in Macrophage Activation Research
Introduction
Piero Ricchiuto is a notable inventor based in Milan, Italy. He has made significant contributions to the field of macrophage activation research. With a total of 2 patents, his work focuses on innovative methods to modulate immune responses.
Latest Patents
Ricchiuto's latest patents include "PARP9 and PARP14 as key regulators of macrophage activation." This invention relates to compositions and methods for inhibiting macrophage activation by modulating PARP9 and/or PARP14 expression or activity. The methods involve the use of small molecules, RNAi, and antibodies. Another patent, "Method of inhibiting macrophage activation using an inhibitor of PARP9," also focuses on similar compositions and methods. By modulating the expression and/or activity of PARP9 and/or PARP14, Ricchiuto's inventions aim to inhibit monocyte or macrophage M1 activation and inflammation. This research is crucial for treating, preventing, and managing conditions where excessive or sustained inflammation contributes to disease progression.
Career Highlights
Piero Ricchiuto is affiliated with The Brigham and Women's Hospital, Inc., where he continues to advance his research. His work has garnered attention for its potential impact on therapeutic strategies in immunology.
Collaborations
Ricchiuto collaborates with esteemed colleagues, including Takuya Hara and Hiroshi Iwata. Their combined expertise enhances the research efforts in macrophage activation and inflammation.
Conclusion
Piero Ricchiuto's innovative work in macrophage activation research highlights the importance of understanding immune responses. His patents pave the way for new therapeutic approaches to manage inflammation-related conditions.